A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2015

Published: May, 2015 | Pages: 40 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Summary

Global Markets Direct's, 'A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2015', provides an overview of the A. Menarini Industrie Farmaceutiche Riunite Srl's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of A. Menarini Industrie Farmaceutiche Riunite Srl including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the A. Menarini Industrie Farmaceutiche Riunite Srl's pipeline products

Reasons to buy

- Evaluate A. Menarini Industrie Farmaceutiche Riunite Srl's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of A. Menarini Industrie Farmaceutiche Riunite Srl in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the A. Menarini Industrie Farmaceutiche Riunite Srl's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of A. Menarini Industrie Farmaceutiche Riunite Srl and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of A. Menarini Industrie Farmaceutiche Riunite Srl and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
A. Menarini Industrie Farmaceutiche Riunite Srl Snapshot 5
A. Menarini Industrie Farmaceutiche Riunite Srl Overview 5
Key Information 5
Key Facts 5
A. Menarini Industrie Farmaceutiche Riunite Srl - Research and Development Overview 6
Key Therapeutic Areas 6
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products Glance 13
A. Menarini Industrie Farmaceutiche Riunite Srl - Late Stage Pipeline Products 13
Pre-Registration Products/Combination Treatment Modalities 13
Phase III Products/Combination Treatment Modalities 14
A. Menarini Industrie Farmaceutiche Riunite Srl - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
A. Menarini Industrie Farmaceutiche Riunite Srl - Drug Profiles 17
(dexketoprofen + tramadol hydrochloride) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ibodutant 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
sabarubicin 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
fasitibant chloride 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
nepadutant 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ranolazine ER 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Analysis 26
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Target 26
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Route of Administration 28
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Molecule Type 29
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Mechanism of Action 30
A. Menarini Industrie Farmaceutiche Riunite Srl - Recent Pipeline Updates 31
A. Menarini Industrie Farmaceutiche Riunite Srl - Dormant Projects 32
A. Menarini Industrie Farmaceutiche Riunite Srl - Discontinued Pipeline Products 33
Discontinued Pipeline Product Profiles 33
abagovomab 33
A. Menarini Industrie Farmaceutiche Riunite Srl - Company Statement 34
A. Menarini Industrie Farmaceutiche Riunite Srl - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 39
Disclaimer 40

List of Tables

A. Menarini Industrie Farmaceutiche Riunite Srl, Key Information 5
A. Menarini Industrie Farmaceutiche Riunite Srl, Key Facts 5
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Indication, 2015 7
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Stage of Development, 2015 8
A. Menarini Industrie Farmaceutiche Riunite Srl - Monotherapy Products in Pipeline, 2015 9
A. Menarini Industrie Farmaceutiche Riunite Srl - Combination Treatment Modalities in Pipeline, 2015 10
A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products in Pipeline, 2015 11
A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products/ Combination Treatment Modalities, 2015 12
A. Menarini Industrie Farmaceutiche Riunite Srl - Pre-Registration, 2015 13
A. Menarini Industrie Farmaceutiche Riunite Srl - Phase III, 2015 14
A. Menarini Industrie Farmaceutiche Riunite Srl - Phase II, 2015 15
A. Menarini Industrie Farmaceutiche Riunite Srl - Phase I, 2015 16
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Target, 2015 27
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Route of Administration, 2015 28
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Molecule Type, 2015 29
A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Mechanism of Action, 2015 30
A. Menarini Industrie Farmaceutiche Riunite Srl - Recent Pipeline Updates, 2015 31
A. Menarini Industrie Farmaceutiche Riunite Srl - Dormant Developmental Projects,2015 32
A. Menarini Industrie Farmaceutiche Riunite Srl - Discontinued Pipeline Products, 2015 33
A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries 35